14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
TCX vs MLAB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Tucows, Inc (TCX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TCX carries a Unified Composite Score of 44.1/100 (HOLD) at $15.10 (30.5x Forward P/E, -4.3% operating margin), whereas MLAB carries 41.8/100 (SELL) at $134.47 (24.9x Forward P/E, 10.4% operating margin).
Composite vs. Pillar Nuance: While TCX currently prints a higher short-term Unified Composite Score (44.1/100 HOLD vs. MLAB 41.8/100 SELL), MLAB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. -4.3% operating margin) and revenue trajectory (+2.6% vs. +1.4% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TCX vs MLAB. Trailing 12-month operating profitability (TCX -4.3% vs MLAB 10.4%) and valuation multiples (TCX 30.5x vs MLAB 24.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Scientific & Technical Instruments value chain with $781.3M market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment54.4% of Rev ($137M)
90D Engineering Disclosures0 Published
Investor FAQ TCX vs MLAB Key Questions & Quantitative Answers
As of Nov 17, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Tucows, Inc (TCX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TCX carries a Unified Composite Score of 44.1/100 (HOLD) at $15.10 (30.5x Forward P/E, -4.3% operating margin), whereas MLAB carries 41.8/100 (SELL) at $134.47 (24.9x Forward P/E, 10.4% operating margin). Composite vs. Pillar Nuance: While TCX currently prints a higher short-term Unified Composite Score (44.1/100 HOLD vs. MLAB 41.8/100 SELL), MLAB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. -4.3% operating margin) and revenue trajectory (+2.6% vs. +1.4% YoY).
MLAB leads the Growth & Scale pillar: TCX posts +1.4% YoY revenue growth and +90.2% YoY earnings growth on $396M TTM revenue (36.5% gross margin, -4.3% operating margin), compared with MLAB at +2.6% YoY revenue growth and +67.0% YoY earnings growth on $251M TTM revenue (64.8% gross margin, 10.4% operating margin). On trailing 12-month operating scale, TCX generates $396M in USD-normalized revenue versus $251M for MLAB. In operating R&D and SG&A reinvestment, TCX deploys 40.8% of Rev ($162M) (0 90-day corporate R&D disclosures) versus 54.4% of Rev ($137M) (0 disclosures) for MLAB.
TCX screens cheaper on headline valuation multiples. TCX trades at 30.5x Forward P/E, 30.5x Trailing P/E, 1.89x PEG, and 1.7x EV/Revenue (-5.7% FCF margin), whereas MLAB trades at 24.9x Forward P/E, 119.8x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (19.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TCX (-1011.6% ROE) versus MLAB (3.6% ROE) capital efficiency.
In options market volatility and institutional positioning, TCX carries 67.3% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.23x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.52β · 151% Vol realized risk). By comparison, MLAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.14β · 52% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.